• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Healthcare·6637.TWO
Share

Medical Imaging Corporation Stocks

NT$ 63.3Last Updated 27.07.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

NT$ 51.94M

NT$ 63.3
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Medical Imaging Corporation, actively operating in China, specializes in providing leasing and management solutions for medical imaging technology. Its comprehensive product portfolio includes sophisticated diagnostic devices such as ultrasound equipment and bone density detectors. Beyond imaging, the company also supplies specialized medical infrastructure like emergency rooms and intensive isolation wards, along with advanced intelligent lead plates for radiation protection. Additionally, it engages in the wholesale distribution of a wide range of medical equipment and pharmaceuticals. The company was founded in 1978 and maintains its headquarters in Taipei, Taiwan.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, overpriced on

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 6637.TWO is 163 and suggests 156% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.07.2026 12:03

Brent crude fell below $90: The U.S. and Iran have suspended their exchange of strikes

27.07.2026 10:51

Top Stories This Morning: Oil Prices Drop 5%, CXMT Hits New Records, OpenAI Builds a Mega Data Center

27.07.2026 10:19

Four Mag7 Reports, the Fed's Decision, and Oil Prices: What Investors Can Expect This Week

26.07.2026 21:33

Revolut Valued at $115 Billion and a Record-Breaking Deal in Asia: Key Takeaways on IPOs as of July 26

26.07.2026 15:01

AI Tools to Combat Cognitive Biases: How Investors Can Use Them

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026